Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
303
NCT05259280
Observational Study of the Wellinks Solution Impact on Quality of Life and Clinical Outcomes in Patients With COPD
Phase: N/A
Role: Lead Sponsor
Start: Jan 5, 2022
Completion: Sep 8, 2022
NCT05330507
Prospective, Observational Study of Wellinks Effect on COPD Hospital Readmissions
Start: Jul 5, 2022
Completion: Jun 30, 2024